Eye drops aim to boost blood flow in glaucoma suspects
NCT ID NCT04401982
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study compares two eye drop treatments—latanoprost alone versus a combination of netarsudil and latanoprost (Rocklatan)—to see if the combination improves blood flow in the veins around the eye. Researchers will use special imaging techniques to measure blood flow in adults with ocular hypertension or suspected glaucoma. The goal is to understand whether adding netarsudil can increase blood flow beyond what latanoprost does alone.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Rocklatan (netarsudil/latanoprost) and latanoprost
What this could lead to
If successful, this could show that netarsudil improves eye blood flow, potentially leading to better treatments for glaucoma.
What could go wrong
This is a small, early-phase study focused on measuring blood flow, not on long-term outcomes. The results may not translate to better vision or disease control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OCULAR HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- TFC-003 Eye Drops for Glaucoma Trial (NCT07662759)
- Bimatoprost Drug Ring for Glaucoma Trial NCT07641296
- MINIject Glaucoma Implant Long-Term Safety Study NCT04524416
- Rhopressa vs Placebo for Glaucoma After SLT – NCT06865144
- Ocular Surface Microbiome in Glaucoma Patients (NCT07643077)
- Glaucoma Eye Drop Trial (NCT07617532)
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Maryland Eye Consultants and Surgeons
RECRUITINGSilver Spring, Maryland, 20902, United States
Contact
Contact
-
UM Faculty Physicians, Inc. | 5900 Waterloo Crossing
RECRUITINGColumbia, Maryland, 21045, United States
Contact Phone: •••-•••-••••
Contact
-
University Physicians Inc.
RECRUITINGBaltimore, Maryland, 21201, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Maryland Medical Center
RECRUITINGBaltimore, Maryland, 21201, United States
Contact Email: •••••@•••••